The earnings call reflects a strong quarter for Aytu BioPharma with significant revenue growth, operational efficiencies, and improved financial metrics. The company's strategic initiatives are yielding positive results, although there are some challenges related to gross margin and potential macroeconomic impacts. Overall, the sentiment is positive, driven by the company's financial achievements and growth trajectory.

Company Guidance -

Q4 2025

During the fiscal 2025 third quarter earnings call for Aytu BioPharma, the company reported significant positive growth across several key metrics. Total revenue increased by 32% year-over-year, driven by a 25% rise in the ADHD portfolio and a 77% surge in the pediatric portfolio. Operating income reached $2.4 million, marking the second consecutive quarter of positive income from operations, while net income was $4 million, a substantial improvement from a $2.9 million loss in the prior year. Basic earnings per share were $0.65 compared to a $0.52 loss per share a year ago. Adjusted EBITDA also saw a remarkable rise to $3.9 million from $0.9 million in the previous year. The company highlighted the success of its Aytu RxConnect platform, which facilitated strong channel and dispensing insights, contributing to improvements in gross-to-nets and overall financial performance.

Significant Revenue Growth

Total revenue grew 32%, driven by a 25% increase in the ADHD portfolio and a 77% increase in the pediatric portfolio.

Positive Income from Operations

Income from operations was $2.4 million, marking the second quarter with positive income from operations in the company's history.

Record Net Income

Net income reached $4 million, compared to a $2.9 million loss in the year-ago quarter.

Improved Earnings Per Share

Basic earnings per share was $0.65, compared to a $0.52 loss in the previous year.

Increased Adjusted EBITDA

Adjusted EBITDA was $3.9 million, up from $0.9 million in the previous year.

Operational Efficiency

Operating expenses decreased by $1.6 million due to cost reduction initiatives.

Strong Performance of Aytu RxConnect

RxConnect continues to be a differentiator, with over 85% of scripts driven through its network.

Aytu BioScience (AYTU) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

AYTU Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Sep 25, 2025	2025 (Q4)	-0.03 / -	-0.82	―	―	―
May 14, 2025	2025 (Q3)	-0.17 / 0.20	-0.52	138.46% (+0.72)	―
Feb 12, 2025	2025 (Q2)	-0.28 / -0.28	-0.04	-600.00% (-0.24)	―
Nov 13, 2024	2025 (Q1)	-0.34 / -0.20	-1.48	86.49% (+1.28)	―
Sep 26, 2024	2024 (Q4)	-0.45 / -0.82	-0.59	-38.98% (-0.23)	―
May 15, 2024	2024 (Q3)	-0.64 / -0.52	-1.93	73.06% (+1.41)	―
Feb 14, 2024	2024 (Q2)	-0.25 / -0.04	-2.15	98.14% (+2.11)	―
Nov 14, 2023	2024 (Q1)	-0.04 / -1.48	-1.2	-23.33% (-0.28)	―
Sep 27, 2023	2023 (Q4)	-0.95 / -0.59	-9.8	93.98% (+9.21)	―
May 11, 2023	2023 (Q3)	-0.63 / -1.93	-35.8	94.61% (+33.87)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

AYTU Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 14, 2025	$1.35	$2.59	+91.85%
Feb 12, 2025	$1.39	$1.38	-0.72%
Nov 13, 2024	$1.74	$1.55	-10.92%
Sep 26, 2024	$2.85	$2.36	-17.19%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Aytu BioScience Inc (AYTU) report earnings?

Aytu BioScience Inc (AYTU) is schdueled to report earning on Sep 25, 2025, TBA (Confirmed).

What is Aytu BioScience Inc (AYTU) earnings time?

Aytu BioScience Inc (AYTU) earnings time is at Sep 25, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is AYTU EPS forecast?

AYTU EPS forecast for the fiscal quarter 2025 (Q4) is -0.03.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing